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TetramethylenedisulfotetramineTetramethylenedisulfotetramine (TETS) is a potent convulsant poison for which there is currently no approved
antidote. The convulsant action of TETS is thought to be mediated by inhibition of type A gamma-aminobutyric
acid receptor (GABAAR) function.We, therefore, investigated the effects of post-exposure administration of diaz-
epam, a GABAAR positive allosteric modulator, on seizure activity, death and neuroinﬂammation in adult male
Swiss mice injected with a lethal dose of TETS (0.15 mg/kg, ip). Administration of a high dose of diazepam
(5 mg/kg, ip) immediately following the second clonic seizure (approximately 20min post-TETS injection) effec-
tively prevented progression to tonic seizures and death. However, this treatment did not prevent persistent
reactive astrogliosis andmicroglial activation, as determined byGFAP and Iba-1 immunoreactivity andmicroglial
cell morphology. Inhibition of soluble epoxide hydrolase (sEH) has been shown to exert potent anti-
inﬂammatory effects and to increase survival inmice intoxicatedwith other GABAAR antagonists. The sEH inhib-
itor TUPS (1 mg/kg, ip) administered immediately after the second clonic seizure did not protect TETS-
intoxicated animals from tonic seizures or death. Combined administration of diazepam (5 mg/kg, ip) and
TUPS (1 mg/kg, ip, starting 1 h after diazepam and repeated every 24 h) prevented TETS-induced lethality and
inﬂuenced signs of neuroinﬂammation in some brain regions. Signiﬁcantly decreased microglial activation and
enhanced reactive astrogliosis were observed in the hippocampus, with no changes in the cortex. Combining
an agent that targets speciﬁc anti-inﬂammatory mechanisms with a traditional antiseizure drug may enhance
treatment outcome in TETS intoxication.
© 2014 Elsevier Inc. All rights reserved.ce interval; DZP, diazepam; EEG,
yric acid receptor; GFAP, glial ﬁ-
matoxylin and eosin; Iba-1, ion-
al; PTZ, pentylenetetrazole; sEH,
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Tetramethylenedisulfotetramine (TETS; tetramine; TMDT) is a
heteroadamantane compound originally synthesized as a condensation
product of sulfamide and formaldehyde (Wood and Battye, 1933). It
was subsequently found to be a highly toxic convulsant poison and
was widely used as a rodenticide until banned in China in 1984
(Whitlow et al., 2005). TETS is, however, still produced illicitly and has
been implicated in the accidental or intentional poisoning of as many
as 14,000 individuals in China between 1991 and 2010, as well as
more than 50 human poisonings in Western countries since 2002 (Li
et al., 2012; Zhang et al., 2011). TETS meets the criteria for inclusion in
the World Health Organization's list of “extremely hazardous pesti-
cides” (Whitlow et al., 2005) and is considered a high priority chemical
threat agent by the National Institutes of Health (Jett and Yeung, 2010).
Based on clinical reports, exposure to low doses of TETS causes diz-
ziness and headaches while high dose exposures trigger acute seizures
Fig. 1. Chemical structures of (A) the cage convulsant 2,6-dithia-1,3,5,7-tetraazatricyclo-
[3.3.1.13,7]decane-2,2,6,6-tetraoxide (TETS) and (B) the soluble epoxide hydrolase inhib-
itor 1-(1-methylsulfonyl-piperidin-4-yl)-3-(4-triﬂuoromethoxy-phenyl)-urea (TUPS).
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doses of TETS can cause persistent neurologic sequelae in survivors, in-
cluding epileptogenesis that lasts for years following the initial expo-
sure to TETS (Bai et al., 2005; Barrueto et al., 2003; Li et al., 2012;
Whitlow et al., 2005). Recently, our group characterized rodent models
of acute TETS intoxication, which conﬁrmed the high potency of TETS as
a convulsant in mice and rats (Zolkowska et al., 2012). Our ﬁndings
were conﬁrmed in a study by Shakarjian et al. (2012), which demon-
strated that treatment with high dose diazepam (5 mg/kg, ip), a
GABAAR positive allosteric modulator, protected adult male C57BL/6
mice from furthermotor seizures and increased survival at 1 h following
TETS exposure. This is consistentwith experimental evidence indicating
that TETS is a noncompetitive antagonist of the GABAAR [reviewed by
Zhao et al., 2014]. However, this high dose of diazepam did not stop
electrographic seizures, and the animals died several hours after treat-
ment (Shakarjian et al., 2012). These observations are consistent with
case reports indicating that benzodiazepine therapy is not always efﬁca-
cious in treating humans poisonedwith TETS (Lu et al., 2008; Poon et al.,
2005). Collectively, these data suggest that benzodiazepines alone are
insufﬁcient to protect against acute TETS poisoning.
Emerging evidence implicates neuroinﬂammation, speciﬁcally reac-
tive astrogliosis andmicroglial activation, in the pathogenesis of sponta-
neous recurrent seizures following SE (Clasadonte et al., 2013; Devinsky
et al., 2013; Hunt et al., 2013; Pineda et al., 2013; Rossi et al., 2013). In-
terestingly, we found in our earlier study that exposure to sublethal
convulsant doses of TETS signiﬁcantly increased reactive astrogliosis
and microglial activation in the cortex and hippocampus of Swiss mice
several days after TETS exposure (Zolkowska et al., 2012). This suggests
the possibility that combinatorial therapywith anticonvulsant and anti-
inﬂammatory agents may better protect the brain following acute TETS
intoxication. Epoxygenated fatty acids are produced in the brain and
have been shown to be potent anti-inﬂammatory compounds (Iliff
and Alkayed, 2009; Inceoglu et al., 2007; Wang et al., 2013). The bene-
ﬁcial effect of these naturally occurring epoxy fatty acids is severely lim-
ited by their rapid metabolism via soluble epoxide hydrolase (sEH)
(Imig and Hammock, 2009; Newman et al., 2005). Pharmacologic inhi-
bition of sEH stabilizes these bioactive molecules (Spector and Norris,
2007) and small molecule sEH inhibitors (sEHI) have been shown to
have signiﬁcant anti-inﬂammatory and neuroprotective activity in ani-
mal models of pain, inﬂammation and ischemic stroke (Iliff and
Alkayed, 2009; Inceoglu et al., 2008; Wang et al., 2013). In addition,
we recently demonstrated that sEHI pretreatment delays the onset of
clonic seizures and prevents lethality in NIH Swiss mice exposed to a le-
thal dose of other GABAA receptor antagonists, including picrotoxin and
pentylenetetrazole (PTZ) (Inceoglu et al., 2013).
The goal of this study was to characterize the effects of high dose di-
azepam administered alone or in combination with the sEHI TUPS on
TETS-induced seizures, death and neuroinﬂammation. Neuroinﬂamma-
tion was assessed by quantifying GFAP and Iba-1 immunoreactivity as
biomarkers of reactive astrogliosis andmicroglial activation, respective-
ly, in the cortex andhippocampus,which are key brain regions implicat-
ed in the generation of seizures (Hunt et al., 2013). Our ﬁndings support
the argument that a combinatorial approach targeting different patho-
genic mechanisms of acute TETS intoxication may be more efﬁcacious
than using benzodiazepines alone to protect the brain following acute
TETS intoxication.
Materials and methods
Chemicals. Paraformaldehyde, sulfamide, hydrochloric acid, acetone,
and hexane were obtained from Thermo Fisher Scientiﬁc (Waltham,
MA). All chemicals were of the highest purity available. TETS was syn-
thesized as previously described (Zolkowska et al., 2012). A ﬁnal recrys-
tallization step was performed to ensure no water remained in the
crystals and characterization of the ﬁnal product by gas chromatogra-
phy–mass spectrometry supported a purity of N98%. USP gradediazepam manufactured by Hospira (in 40% propylene glycol, 10%
alcohol, 5% sodium benzoate and 1.5% benzyl alcohol) was purchased
from Western Medical Supply (Arcata, CA). The sEHI TUPS (1-(1-
methanesulfonyl-piperidin-4-yl)-3-(4-triﬂuoromethoxy-phenyl)-urea
was synthesized as previously described (Tsai et al., 2010). TETS was
dissolved in 100% DMSO and stored as stock solutions at 10 mg/ml.
TUPSwas formulated in pure polyethylene glycol 400 (PEG400). Chem-
ical structures of TETS and TUPS are illustrated in Fig. 1.
Animals. Animals were maintained in facilities fully accredited by the
Association for Assessment and Accreditation of Laboratory Animal
Care, and all studies were performed under protocols approved by the
UC Davis Institutional Animal Care and Use Committee. Male NIH
Swiss mice (22–25 g) were obtained from the Animal Resource Pro-
gram, Center for Cancer Research, National Cancer Institute (Bethesda,
MD) andwere housed four per cage. All animalswere kept in a vivarium
under controlled environmental conditions (22–26 °C; 40–50% humid-
ity) with a 12 h normal light/dark cycle and free access to food and
water. Animals were allowed to acclimate to the vivarium for at least
5 days prior to experimentation. Experiments were performed during
the light phase of the light/dark cycle after at least 30min of acclimation
to the laboratory setting.
Dosing paradigm. Micewere randomly divided into the following 4 treat-
ment groups: (1) TETS+ diazepam, (2) TETS vehicle (10% DMSO in ster-
ile saline) + diazepam, (3) TETS + diazepam + TUPS, and
(4) TETS + diazepam + TUPS vehicle (PEG400). On the day of each
experiment, stock solutions of TETS were sequentially diluted in saline
with 10% DMSO at 40–60 °C to a ﬁnal concentration of 0.015 mg/ml.
TETS solutions were kept at 35–36 °C and administered ip in a volume
of 10 ml/kg. Immediately after dosing, animals were observed for up
to 60 min for seizure behavior, and time to seizure onset and duration
of each seizure were recorded for each animal. Mice in treatment
groups 3 and 4 also received either TUPS (1 mg/kg, ip) or an equal vol-
ume (1 ml/kg) of vehicle (PEG400) 1 h following treatment with diaz-
epam, and every 24 h thereafter until euthanized.
Electroencephalogram (EEG) recording. EEG recordings were obtained in
a subset of animals to validate behavioral seizure scoring. To place
electrodes, mice were anesthetized using a mixture of ketamine
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implanted with a 2 EEG/1 EMG mouse head mount (8201 mouse head
mount, Pinnacle Technology, Lawrence, KS). The headmountwas afﬁxed
to the skull with stainless steel screws that also acted as EEG electrodes.
The front edge of the implantwas placed 3.0–3.5mmanterior of bregma.
In this conﬁguration, all four screws rest on the cerebral cortex. The right
frontal (EEG2) and parietal (EEG1) screws were used for EEG recording.
The lowest noise EEG signal was selected for display in Fig. 2; both EEG
signals are shown in Supplementary Fig. 2C. EMG electrodes were im-
planted in the neck. EEG recordings were conducted with respect to
the left parietal cortex. The left frontal screw electrode was ground.
Mice were allowed to recover for 1 week before initiating experimenta-
tion. On the day of each experiment,micewere acclimated to the record-
ing cage and a 30 min baseline recording was obtained prior to
administration of TETS (0.15 mg/kg, ip).Within 1–2min after the second
clonic seizure, diazepam (5 mg/kg, ip) was administered to half the ani-
mals. Following diazepam administration, EEG activity was continuously
recorded for at least 1 h in each mouse. EEG signals were acquired and
analyzed using Sirenia software (Pinnacle Technology).Fig. 2.Diazepam blocks TETS-induced tonic seizures and preventsmortality when administered af
perienced two clonic seizures followed by a tonic seizure. All animals died within minutes of exh
immediately following the second clonic seizure prevented subsequent seizures and signiﬁcantly
and duration of seizures are expressed as themean±SE. Representative EEG recordings are shown
(top trace) or diazepam (bottom trace). EEG recordings for 1 h post-TETS exposure in animals re
cludes additional EEG traces from other animals (Figs. S1A and B), and a trace with a ﬁner tempoHistology. At 1, 2, 3 and 7 days post-TETS exposure, anesthetized mice
were serially perfused with ice-cold saline and 4% paraformaldehyde.
Fixed brains were ﬂash frozen in O.C.T. compound (Sakura Finetek, Tor-
rance, CA) and cutwith a cryostat into 10 μmsagittal sections. Hematox-
ylin and eosin (H&E) staining was used to assess tissue integrity while
Fluoro-Jade B (FJB) staining was used to identify neuronal cell damage
as previously described (Zolkowska et al., 2012). To assess reactive
astrogliosis and microglial cell activation, brain sections adjacent to
those used for histological assessment were immunostained for glial ﬁ-
brillary acidic protein (GFAP) or ionized calcium binding adaptor
molecule-1 (Iba-1), respectively, as previously described (Zolkowska
et al., 2012). GFAP and Iba-1 immunoreactivity were visualized by
confocal microscopy and quantiﬁed using image analysis software
(Metamorph, Molecular Devices, Sunnyvale, CA) as previously de-
scribed (Zolkowska et al., 2012). Individuals blinded to the treatment
condition determined the number of activated versus resting Iba-1
immunopositive microglia according to published morphologic criteria
(Matthews and Kruger, 1973). Activated versus resting microglia were
quantiﬁed across the entire hippocampus and along the entire dorsalter the second clonic seizure. (A) Animals administered TETS at 0.15 mg/kg (ip) typically ex-
ibiting tonic-clonic seizures (n = 68 animals). (B) Administration of diazepam (5 mg/kg, ip)
reducedmortality as evidenced by a survival rate of N 99% (n= 142 animals). Time-to-onset
frommice administered TETS (0.15 mg/kg, ip)with post-exposure administration of vehicle
scued by diazepam conﬁrmed no additional seizure activity. The supplementary data ﬁle in-
ral resolution (Fig. S1C).
Fig. 3. Post-exposure administration of diazepam (DZP) does not prevent reactive
astrogliosis in mice acutely intoxicated with TETS. (A) Representative photomicrographs
of H&E staining (top panels) and GFAP immunoreactivity (bottom panels) in the hippo-
campus 3 days post-injection of mice exposed to either vehicle or TETS (0.15 mg/kg, ip)
followed by administration of diazepam (5 mg/kg, ip) ~20 min later. Bar = 50 μm.
(B) The area of GFAP immunoreactivity per ﬁeld was quantiﬁed in the cortex (left) and
hippocampus (right) as ameasure of the number of GFAP-immunopositive cells. Dots rep-
resent the geometric mean ratio of TETS + diazepam versus vehicle + diazepam-treated
animals; bars represent 95% conﬁdence intervals (n = 3–6 animals per treatment). Data
from individual animals within each treatment group are provided in the Supplementary
Data ﬁle (Fig. S2).
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edge. All endpoints were examined in at least 3 serial sections per ani-
mal and data were collected from the same level of the brain across all
animals.
Statistical analyses. Histological data were analyzed using Stata 13 soft-
ware (StataCorp, College Station, TX). Graphics were produced using
the R 3.0.1 software suite (Vienna, Austria; package ggplot2 version
0.9.3.1 by Hadley Wickham). Because ﬂuorescent staining and glial
counts were performed on multiple sections from different brain re-
gions of each animal, mixed-effects regression models employing re-
peated measures taken from the same animal were used to account
for within-animal correlations and to improve the efﬁciency of esti-
mates. Repeated measures analysis of variance (ANOVA) methods
were inappropriate due to missing observations and to their inability
to deal with count outcomes, as in the microglial data.
GFAP and Iba-1 immunostaining were analyzed with respect to the
area of immunoreactivity. Exploratory analysis indicating that a loga-
rithmic transformation of the datawas required to stabilize the variance
and normalize the distribution to accord with the linear model speciﬁ-
cation. Linear mixed effects models with animal random effects were
applied unless residual scatterplots indicated that the error variance
was approximately proportional to the mean. In the latter case, Poisson
mixed effects models (log link) were used. In every model, candidate
ﬁxed effects were as follows: treatment condition, brain region (cortex
or hippocampus), number of days after treatment administration, and
their interactions. Variable selectionwasperformedusing the Akaike in-
formation criterion andWald tests for pairwise comparisons of interac-
tion effects; when interaction termswere not signiﬁcant themodel was
simpliﬁed by removing them. Glial activation data were expressed as
counts and Poissonmixed effectsmodels were appliedwith variable se-
lection proceeding as described above.
Statistical analysis results are presented as geometric mean ratios
between two treatment conditions. These ratios are directly interpret-
able as fold changes. That is, a ratio of 1.5 corresponds to a 50% increase,
and a ratio of 0.5 corresponds to a 50% decrease. In the ﬁgures, point
estimates of the ratio are presented as dotswith the associated 95% con-
ﬁdence interval extending above and below. The conﬁdence interval
provides an indication of the strength of the effect.When the conﬁdence
interval includes 1, there is no statistical evidence of any difference be-
tween the treatment and its comparison group. When the interval does
not include 1, the estimate of the effect is considered signiﬁcant at the
5% level. However, any value lyingwithin the conﬁdence interval is con-
sidered a plausible value for the true treatment effect. Using a fully
interacted model (that is, all interaction terms are included), there is a
conﬁdence interval for every brain region and day number. When the
variable selection process indicated that the model could be simpliﬁed,
the appropriate interaction terms were removed. In this case, the conﬁ-
dence intervals act as a summary measure across brain region, day
number, or both.
Results
Post-exposure administration of diazepam prevents lethality in TETS-
intoxicated mice
Consistentwith previous observations (Zolkowska et al., 2012),mice
dosed with 0.15 mg/kg TETS displayed a brief period of hyperactivity
followed by a brief period of quiescence, Straub tail, twitches, imbal-
ance, clonic seizures, and subsequently, tonic seizures and death. The
majority of animals (N80%) exhibited a period of wild running immedi-
ately prior to the onset of tonus.Mice intoxicatedwith this lethal dose of
TETS exhibited a stereotypic pattern of seizure behavior consisting of
two clonic seizures of short duration (b1 min) beginning within 5 to
6 min after TETS injection, followed by a lethal tonic seizure within
20–30min after TETS injection (Fig. 2A). The time to onset and durationof seizures (Fig. 2A) were as observed previously (Zolkowska et al.,
2012). In the absence of therapeutic intervention, 87% of mice exposed
to TETS survived the two clonic seizures, but none (0%) survived the
tonic seizure. The 13% of animalswho died during this period character-
ized by clonic seizures transitioned to tonus after a single clonic seizure
or immediately following the second seizure. To determinewhether an-
imals could be protected fromdeath by a treatment delivered before the
lethal tonic seizure, diazepam at 5 mg/kg (ip) was administered within
1–2 min after the second clonic seizure (approximately 20 min after
TETS injection). This dose of diazepam was chosen based on previous
studies (Shakarjian et al., 2012). When administered shortly following
the end of the second clonic seizure, diazepam stopped seizure behavior
and prevented mortality in N99% of TETS-intoxicated animals (Fig. 2B).
Administering diazepam at later times (e.g., at the start of the third sei-
zure) also decreasedmortality relative to animals that received no ther-
apeutic intervention, but the results were inconsistent and fewer
animals survived (data not shown).
To assess whether diazepam also terminated electrographic seizure
activity, EEG recordings were performed in TETS-intoxicated mice, a
189S.T. Vito et al. / Toxicology and Applied Pharmacology 281 (2014) 185–194subset of whichwere treatedwith diazepam following the second clon-
ic seizure (n = 4 animals per group). Behavioral seizure activity was
also evaluated throughout the recording period. As shown in represen-
tative EEG recordings of TETS-intoxicated mice (Figs. 2A and B), there
was a good correlation between observations of behavioral seizure ac-
tivity and electrographic seizure activity. Electrographic seizures were
characterized by N5 s of noticeably increased spike amplitude and fre-
quency relative to the baseline signal. In each case, an increased EMG
signal coincident with EEG peaks was recorded (see Supplementary
data, Fig. S1). Treatmentwith diazepam following the second clonic sei-
zure stopped subsequent electrographic seizures for at least 1 h post-
diazepam treatment (Fig. 2B). Diazepam also caused an initial slight
and transient decrease in the amplitude of EEG peaks from baseline
levels. Recordings from the other 3 animals in each treatment group
are provided in the Supplementary data ﬁle (Fig. S1).
Post-exposure administration of diazepam does not prevent TETS-induced
neuroinﬂammation
Our earlier study (Zolkowska et al., 2012) demonstrated that suble-
thal convulsive doses of TETS triggered time- and region-dependent
neuroinﬂammatory responses as determined by GFAP and Iba-1 immu-
nohistochemistry. To determine whether treatment with diazepam
mitigated the neuroinﬂammation associated with TETS-induced sei-
zures, brains were collected at 1, 2, 3, and 7 days post-TETS exposure
from mice injected with TETS (0.15 mg/kg, ip) then rescued with diaz-
epam (5 mg/kg, ip). Mice treated with the vehicle for TETS (10% DMSO
in saline) followed 20 min later by injection with diazepam (5 mg/kg,
ip) were used as controls for these studies. Similar to our earlier reportFig. 4. Post-exposure administration of diazepam (DZP) does not prevent microglial activation
Iba-1 immunoreactivity 3 days post-TETS injection in the cortex (A) and hippocampus (B) of m
epam(5 mg/kg, ip) ~20min later. Bars=50 μm.Microglial activationwas assessed at 1, 2, 3 and
and (D) the number of activatedmicroglia per ﬁeld as determined usingmorphological criteria.
treated animals; bars represent 95% conﬁdence intervals (n = 3–6 animals per treatment). Ana
interactions so thedatawere compressed to a single geometricmean that included all days and r
the Supplementary Data ﬁle (Fig. S3).of sublethal exposures to TETS (Zolkowska et al., 2012), there were no
gross pathological lesions or neurodegeneration in the cortex or hippo-
campus of mice rescued from TETS lethality by diazepam, as indicated
by H&E staining (Fig. 3A) and Fluoro-Jade B staining (data not shown).
However, the cortex and hippocampus of mice rescued from TETS-
induced tonus and death by diazepam (TETS rescue mice) displayed a
time-dependent increase in reactive astrogliosis relative to these same
brain regions of mice treated only with diazepam (Fig. 3B). Calculation
of the geometric mean ratio (GMR) of the area of GFAP immunoreactiv-
ity in the cortices and hippocampi of TETS rescuemice relative to that of
control mice revealed a signiﬁcant decrease in reactive astrogliosis at
1 day post-treatment but a signiﬁcant increase in reactive astrogliosis
at 2 and 3 days post-treatment (Fig. 3B). At 2 days post-treatment, a
10-fold increase in the GMR of the area of GFAP immunoreactivity
was observed in the cortex, whereas a 7-fold increase was observed in
the hippocampus. By 7 days post-exposure, therewas no signiﬁcant dif-
ference in the area of GFAP immunoreactivity between TETS rescue
mice and control animals (Fig. 3B).
The area of Iba-1immunoreactivity was assessed as a biomarker of
microglial activation (Fig. 4). Calculation of the GMR of the area of Iba-
1 immunoreactivity in the cortices and hippocampi of TETS rescue
mice relative to that of control mice indicated that rescue by diazepam
did not block TETS-induced microglial activation in these brain regions
(Fig. 4C). Mice treated with TETS and diazepam exhibited a statistically
signiﬁcant increase (20%) in the area of Iba-1 immunoreactivity in the
cortex and hippocampus at 1, 2, 3 and 7 days post-treatment, suggesting
that microglia were recruited to these brain regions in TETS-intoxicated
animals. Iba-1 immunopositive cells were classiﬁed as resting or activat-
ed microglial cells using morphological criteria (Matthews and Kruger,in mice acutely intoxicated with TETS. Representative ﬂuorescence photomicrographs of
ice exposed to either vehicle or TETS (0.15 mg/kg, ip) followed by administration of diaz-
7 dayspost-TETS injectionwith respect to: (C) the area of Iba-1 immunoreactivity perﬁeld
Dots represent the geometricmean ratio of TETS+ diazepam versus vehicle+ diazepam-
lyses of the area of Iba-1 immunoreactivity revealed no signiﬁcant day- or region-speciﬁc
egions sampled.Data from individual animalswithin each treatment group are provided in
190 S.T. Vito et al. / Toxicology and Applied Pharmacology 281 (2014) 185–1941973). Consistent with results from the quantitative analyses of the area
of Iba-1 immunoreactivity, themorphometric assessment of the number
of activatedmicroglial cells per unit area indicated signiﬁcantly increased
microglial activation in both the cortex and hippocampus of TETS intox-
icated mice compared to controls (Fig. 4D). The temporal proﬁle of
microglial activation differed between brain regions, with signiﬁcant in-
creases observed in the cortex at 1, 2, 3 and 7 days post-TETS exposure
and in the hippocampus at 2 and 3 days post-TETS exposure.Pharmacologic inhibition of soluble epoxide hydrolase (sEH)
differentially modulates TETS-induced reactive astrogliosis and
microglial activation
Since inhibition of sEH has been shown to exert potent anti-
inﬂammatory action (Iliff and Alkayed, 2009; Inceoglu et al., 2008;
Wang et al., 2013), we quantiﬁed the effects of administering TUPS, a
small molecule inhibitor of sEH, on TETS-induced seizures and neuroin-
ﬂammation. Initial experiments focused on determining whether phar-
macologic inhibition of sEH was sufﬁcient to protect against TETS-
induced tonus and death in the absence of diazepam. Pretreatment
with TUPS (1 mg/kg, ip) 1 h prior to injection of a lethal dose of TETS
(0.15 mg/kg, ip) had no effect on clonic seizures but decreased the num-
ber of mice that experienced tonic seizures and died (Figs. 5A and B), al-
though the survival rate was not as high as observed in TETS-intoxicated
mice treated with high dose diazepam following the second clonic sei-
zure. Administration of TUPS to TETS-intoxicated mice immediately fol-
lowing the second clonic seizure did not prevent tonus and death in
the absence of diazepam (Fig. 5C).When administered to TETS intoxicat-
ed mice 1 h after treatment with diazepam (5 mg/kg, ip), TUPS did not
diminish the protective efﬁcacy of diazepam against TETS-induced
tonus and mortality (Fig. 5D).
To determine whether sEH inhibition would prevent TETS-induced
neuroinﬂammation, GFAP and Iba-1 immunoreactivity were quantiﬁedFig. 5. Pretreatment but not post-exposure administration of sEHI reduces TETS lethality. (A) S
efﬁcacy of the sEHI TUPS. (B) Administration of TUPS (1 mg/kg, ip) 1 h prior to TETS protects ag
apeutic experimental paradigm used to evaluate the efﬁcacy of TUPS when administered pos
protecting mice against the TETS-induced tonic seizures and mortality. (D) Schematic repres
TUPS. Administration of TUPS 1 h after injection of diazepam did not alter the rescue of TETS-in
clonic seizure.in the cortex and hippocampus of TETS-intoxicatedmice rescuedwith di-
azepam and then treated with TUPS (1 mg/kg, ip) beginning 1 h after di-
azepam treatment, with repeated administration every 24 h until animals
were euthanized. Controlmicewere similarly treatedwith TETS and diaz-
epam but then administered the TUPS vehicle (PEG400) instead of the
sEHI. The GMR of the area of GFAP immunoreactivity in TETS intoxicated
mice treated with both diazepam and TUPS relative to controls indicated
no signiﬁcant treatment effect in the cortex at 1, 2, 3 or 7 days post-TETS
exposure (Fig. 6). In contrast, the GMR of the area of GFAP immunoreac-
tivity was signiﬁcantly increased in the hippocampus at 1, 2, 3 and 7 days
post-TETS exposure (Fig. 6), indicating that treatment with the sEHI sig-
niﬁcantly enhanced astrogliosis in this brain region.
The effects of TUPS on TETS-induced microglial activation also varied
between the cortex and hippocampus. The GMR of the area of Iba-1 im-
munoreactivity in the cortex of TETS intoxicated mice treated with diaz-
epam and TUPs relative to cortical Iba-1 immunoreactivity in control
mice did not differ signiﬁcantly froma ratio of 1 at any of the times exam-
ined post-TETS exposure (Fig. 7A), indicating no signiﬁcant effect of TUPS
on TETS-induced microglial cell recruitment in the cortex. However, the
GMR of the area of Iba-1 immunoreactivity was signiﬁcantly decreased
in the hippocampus at 1, 3 and 7 days post-TETS exposure (Fig. 7A), indi-
cating that inhibition of sEH signiﬁcantly inhibitedmicroglial recruitment
in the hippocampus. Quantiﬁcation of the number of activated microglia
as identiﬁed using morphometric criteria further indicated that adminis-
tration of TUPS signiﬁcantly decreased microglial cell activation in the
hippocampus, but not the cortex, at 1, 2, 3 and7days post-TETS exposure,
as indicated by a GMR signiﬁcantly b1 in the hippocampus at all post-
exposure times analyzed (Fig. 7B).Discussion
The present study supports and extends our previous characterization
of TETS-induced seizures in adult male NIH Swiss mice (Zolkowska et al.,chematic representation of the experimental paradigm used to evaluate the prophylactic
ainst TETS-induced tonic seizures andmortality. (C) Schematic representation of the ther-
t-TETS exposure. Inhibition of sEH following the second clonic seizure was ineffective in
entation of the experimental paradigm used to evaluate polytherapy with diazepam and
toxicatedmice by diazepam (5 mg/kg ip) administered immediately following the second
Fig. 6. Combinatorial post-exposure treatment with diazepam and the soluble epoxide hy-
drolase inhibitor (sEHI) TUPSmodulates reactive astrogliosis in a region-dependentmanner.
Todeterminewhether inhibitionof sEHalters TETS-induced reactive astrogliosis, TETS-intox-
icatedmicewere administered TUPS (1 mg/kg, ip) or an equal volume of vehicle (PEG400) 1
h following rescue with diazepam (5 mg/kg, ip) with additional sEHI injection every 24 h
until animals were euthanized. (A) Representative photomicrographs of H&E staining (top)
and GFAP immunoreactivity (bottom) in the hippocampus 3 days post-TETS injection of
mice treated with diazepam followed by either vehicle or sEHI. Bars = 50 μm. (B) The area
of GFAP immunoreactivity per ﬁeld was quantiﬁed as a measure of the number of GFAP-
immunopositive cells. Combinatorial therapy had no signiﬁcant effect on reactive astrogliosis
in the cortex, but caused a signiﬁcant, albeit modest, increase in the hippocampus. Dots rep-
resent thegeometricmean ratio of TETS+ diazepam+sEHI versus TETS+ diazepam+ ve-
hicle-treated animals; bars represent 95% conﬁdence intervals (n = 3–6 animals per
treatment). Data from individual animals within each treatment group are provided in the
Supplementary Data ﬁle (Fig. S4).
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electrographic seizure activity, and that “rescue therapy” with a high
dose of diazepam (5 mg/kg, ip) administered upon cessation of thesecond clonic seizure (approximately 20 min post-TETS) effectively
stops both behavioral and electrographic seizures for at least 1 h. This ex-
tends the therapeutic window of 3–5 min post-TETS for high dose diaze-
pam rescue previously reported for adult male C57BL/6 mice intoxicated
with a lethal dose of TETS (Shakarjian et al., 2012).We also observed that
rescue therapywith diazepamprevented death in TETS-intoxicatedmice,
as evidenced by N99% survival at 24 h post-TETS exposure. These rescued
animals remained healthy and did not exhibit behavioral seizures or
weight loss during the period prior to euthanasia, which ranged from 1
to 7days after TETS injection.Our observations are in contrast to an earlier
report (Shakarjian et al., 2012) inwhich administration of high dose diaz-
epam (5 mg/kg, ip) 3–5min after TETS injection in C57BL/6mice tempo-
rarily terminated behavioral seizure activity and prevented immediate
lethality for about 2 h, but did not stop ongoing electrographic seizures
and death at 4–8 h. In our studies thus far [(Zolkowska et al., 2012)
and the present study], we have not observed continuous behavioral
or electrographic SE. Possible reason(s) for the discrepancies between
our studies of NIH Swiss mice and the earlier studies of C57BL/6 mice
(Shakarjian et al., 2012) include: (1) strain differences in seizure sus-
ceptibility (Esplin et al., 1994; McKhann et al., 2003; McLin and
Steward, 2006;McLin et al., 2006; Schauwecker, 2012, 2013); (2) strain
differences in TETS or diazepam pharmacokinetics; and (3) differences
in the total injected dose of TETS (0.15 mg/kg, ip in NIH Swissmice ver-
sus 0.4 mg/kg, ip in C57BL/6mice). If the latter is a contributing factor, it
suggests that the therapeutic efﬁcacy of benzodiazepines for treating
humans poisoned with TETS may depend on the total body burden of
TETS; high TETS exposures may be more difﬁcult to treat.
A key ﬁnding of the present study is that even though high dose diaz-
epam effectively stopped behavioral and electrographic seizures and
prevented mortality in TETS-intoxicated mice, it did not mitigate the
neuroinﬂammatory response to sublethal and lethal doses of TETS
(Zolkowska et al., 2012), as evidenced by increased GFAP and Iba-1 im-
munoreactivities in both the hippocampus and cortex. The spatiotempo-
ral proﬁle of GFAP immunoreactivity was similar, but the magnitude of
the response greater than, and the microglial response generally oc-
curred earlier and persisted longer than those previously reported in
TETS-intoxicated mice not treated with diazepam (Zolkowska et al.,
2012). Seizures induced by GABAAR antagonists are believed to involve
generalized thalamo-cortical mechanisms and are distinguished from
limbic-like seizures involving the hippocampus and other temporal
lobe structures (Velisek, 2005). However, intense GABAA receptor antag-
onist-induced seizures strongly recruit hippocampal structures, includ-
ing the dentate gyrus and to a lesser extent CA3 and CA1 (Willoughby
et al., 1995). Therefore, it is not surprising that astrocytic changes were
observed in the hippocampus and cortex.
Neuroinﬂammation has been observed in a number of seizure
models. Electroconvulsive seizures (Steward, 1994) and kindled seizures
(Steward et al., 1992) as well as organophosphate nerve agent-induced
seizures (Baille-Le Crom et al., 1995; Baille et al., 2005; Liu et al., 2012;
Zimmer et al., 1997) and kainic acid-induced SE (Drexel et al., 2012;
Ravizza et al., 2005; Rizzi et al., 2003) are associated with reactive
astrogliosis. Prolonged seizures have also been shown to rapidly activate
microglia (Baille et al., 2005; Du et al., 1993; Rizzi et al., 2003; Zimmer
et al., 1997). Based on data collected in these seizure models, it is postu-
lated that the neuroinﬂammatory response is a consequence of neurode-
generation, and that the extent or severity of neurodegeneration and
neuroinﬂammation is directly correlated to the duration and/or intensity
of seizure activity (Drexel et al., 2012; McDonough et al., 1995, 1998;
Shih et al., 2003). However, in our previous study of sublethal exposures
to TETS in the absence of diazepam (Zolkowska et al., 2012) and in this
study of TETS rescue mice, reactive astrogliosis and microglial activation
were observed in the absence of overt neuronal injury and cell death.
Moreover, the persistence and/or magnitude of the neuroinﬂammatory
response were greater in the TETS rescue mice relative to that observed
in the TETS intoxicated mice not treated with diazepam (Zolkowska
et al., 2012) even though the behavioral seizures in the TETS rescue
Fig. 7. Post-exposure combinatorial therapy with diazepam (DZP) and the sEHI TUPS decreases microglia activation. Mice were exposed to TETS (0.15 mg/kg, ip) followed ~20 min later
with diazepam (5 mg/kg, ip) and1h laterwith either vehicle or TUPS (1 mg/kg, ip).Microglia activationwas assessed in these 2 brain regions at 1, 2, 3 and 7 dayspost-TETS intoxication by
quantifying: (A) the area of Iba-1 immunoreactivity per ﬁeld and (B) the number of activatedmicroglia per ﬁeld as determined usingmorphological criteria. Dots represent the geometric
mean ratio of TETS+ diazepam+TUPS versus TETS+ diazepam+ vehicle; bars represent 95% conﬁdence intervals (n=3–6 animals per treatment). Data from individual animalswith-
in each treatment group are provided in the Supplementary Data ﬁle (Fig. S5).
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intoxicated mice not treated with diazepam (Zolkowska et al., 2012).
Collectively, these ﬁndings suggest that, contrary to current dogma, neu-
roinﬂammation is not a consequence of neurodegeneration, and it is not
correlated with the duration of seizure activity. These observations also
suggest that TETS-induced neuroinﬂammation ismediated by pathogen-
ic mechanisms other than those that underlie TETS-induced seizures, a
possibility reinforced by the observation that diazepam, a GABAAR posi-
tive allosteric modulator, stops TETS-induced seizures, but not TETS-
induced neuroinﬂammation.
The observation that diazepam prevented death but did not mit-
igate the neuroinﬂammatory response in TETS intoxicated mice sug-
gests that the neuroinﬂammation triggered by TETS likely does not
contribute to lethality. However, it does raise the possibility that
once triggered, neuroinﬂammation develops independently and per-
haps contributes to chemical-induced epilepsy or spontaneous recurrent
seizures (Clasadonte et al., 2013; Devinsky et al., 2013; Hunt et al., 2013;
Pineda et al., 2013; Rossi et al., 2013).Whilewe did not see any behavior-
al evidence of spontaneous recurrent seizures in mice that survived a le-
thal dose of TETS, this possibility cannot be ruled out in the absence of
continuous EEG monitoring over longer periods of time post-exposure.
If true, this possibility reinforces the rationale that combining an antisei-
zure agent and a speciﬁc anti-inﬂammatory treatmentmay be amore ef-
fective therapeutic approach than using an antiseizure agent alone. To
test this possibility, we employed a small molecule inhibitor of the en-
zyme sEH. This cytosolic enzyme regulates the levels of the epoxy fatty
acids, which are bioactive lipid metabolites with anti-inﬂammatory
properties (Iliff and Alkayed, 2009; Inceoglu et al., 2007). The anti-
inﬂammatory effects of epoxy fatty acids and sEHIs have been demon-
strated in other models of neuroinﬂammation, including a mouse
model of scrapie (Poli et al., 2013), amousemodel of neurodegeneration
following cardiac arrest (Wang et al., 2013), and an in vitromodel of am-
yloid peptide-induced neurotoxicity (Sarkar et al., 2011).We have previ-
ously shown that epoxy fatty acids and sEHIs protect against seizures
induced by PTZ, and this anticonvulsant activity seems to be mediated,
in part, by augmentation of GABAergic signaling (Inceoglu et al., 2013).
These observations suggested that sEHIs may protect against both the
convulsant and neuroinﬂammatory actions of TETS.We found that phar-
macologic inhibition of sEHwith TUPS increased survival when adminis-
tered prior to TETS; however, in contrast to observations of PTZ-inducedseizures (Inceoglu et al., 2013), TUPS did not delay the onset of TETS-
induced seizures (Inceoglu, unpublished observations). Moreover, TUPS
did not stop TETS-induced seizureswhen administered following the sec-
ond clonic seizure. These ﬁndings are consistentwith our earlier observa-
tions that the toxic proﬁle of TETS varies from that of picrotoxin and PTZ
(Zolkowska et al., 2012), and reinforces the hypothesis that TETS may
have mechanisms of toxicity in addition to GABAAR antagonism.
Pharmacologic inhibition of sEH did, however, modulate the
neuroinﬂammatory response in TETS-intoxicated mice rescued by diaze-
pam, increasing reactive astrogliosis and decreasingmicroglial activation.
Interestingly, these sEHI-related changes in neuroinﬂammation were ob-
served in the hippocampus but not in the cortex. The reason for the
region-dependent effects is not known, nor is it known why sEHI exerts
differential effects on astrocytes versus microglial cells. The sEH enzyme
is localized to astrocytes (Marowsky et al., 2009; Rawal et al., 2009;
Sura et al., 2008) where it is thought to regulate levels of epoxy fatty
acids in the brain (Marowsky et al., 2009; Terashvili et al., 2012), but
there is very little information regarding the expression or function of
sEH in microglial cells. Similarly, there is little known about the effect of
sEH inhibition on the activational status of either astrocytes or microglial
cells with the exception of a recent report that pharmacologic inhibition
of sEH alters the transcriptional proﬁle of activatedmicroglia to selective-
ly induce anti-inﬂammatory and neuroprotective cytokine expression
(Wang et al., 2013).
Perhaps the more important question raised by these data is the
functional signiﬁcance of increased reactive astrogliosis and decreased
microglial activation with sEHI treatment. The impact of these changes
is difﬁcult to predict since there is evidence that microglial activation
can be detrimental in some circumstances and beneﬁcial in others
(Harry, 2013). Similarly, there is evidence that activated astrocytes
can cause or exacerbate neuronal injury (Davalos et al., 2005; Liu
et al., 2011) or play a neuroprotective role following brain and spinal
cord injury via secretion of anti-inﬂammatory factors that suppress
the activation of microglia (Faulkner et al., 2004; Tichauer et al., 2007;
Zhao et al., 2003). In a model of organophosphate nerve agent-induced
seizures, neuronal cell death is reducedwhen there is increased astrocyte
activation and is increased when the number of activated astrocytes de-
creases (Collombet et al., 2005, 2007). The protective role of activated as-
trocytes in this model is thought to be mediated by the release of
neuroprotective cytokines (Collombet, 2011). Functional studies are
193S.T. Vito et al. / Toxicology and Applied Pharmacology 281 (2014) 185–194needed to determine whether the modulation of neuroinﬂammation by
sEH inhibition is of therapeutic value, but based on observations in the
organophosphate nerve agent-induced seizure model (Collombet,
2011), it seems plausible that the enhanced reactive astrogliosis and de-
creasedmicroglial activation observed following sEHI treatment is a ben-
eﬁcial outcome.
In summary, our ﬁndings suggest that TETSmay havemechanisms of
toxicity in addition to GABAAR antagonism that lead to neuroinﬂamma-
tion. Diazepam, a GABAAR positive allosteric modulator, effectively
protected against seizures and lethality when administered up to
20 min after TETS injection; however, diazepam was ineffective in miti-
gating TETS-induced neuroinﬂammation. In the treatment of TETS intox-
ication, administering an agent that targets relevant anti-inﬂammatory
mechanisms as an adjunct to a traditional antiseizure agent may lead
to better therapeutic outcomes.
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